20th Annual WRIB Meeting
April 13-17, 2026
Dallas, TEXAS
Visit us at BOOTH #37
Join us at WRIB 2026 to discuss your bioanalytical strategy, regulatory pathway, and data delivery needs, backed by proven science and scalable execution.
.png?width=2000&height=850&name=20WRIB%20Logo_white%20(1).png)
BIOANALYTICAL EXPERTISE DESIGNED FOR REAL WORLD DRUG DEVELOPMENT
BioAgilytix is a global bioanalytical CRO supporting complex drug development programs with scientific rigor, proven regulatory expertise, and the operational scale required to deliver high-quality, compliant data, on time and with confidence.
We provide integrated bioanalytical services, including pharmacokinetic (PK), immunogenicity, biomarker, and CMC analytical testing, to pharmaceutical and biotechnology partners across every phase of development.
Our global laboratories deliver immunoassay, cell-based, molecular biology, and LC/MS assay development, validation, and sample testing within a unified quality framework, reducing handoffs, increasing consistency, and strengthening data integrity.
From early preclinical research through late-stage clinical trials, our teams take a customized, scientifically grounded approach—aligning methods, timelines, and compliance strategies to your program’s specific needs.
AUTOMATION SUPPORTING QUALITY-TODAY AND AT SCALE
At BioAgilytix, automation isn’t just a feature.
It’s how we’re building the next generation of bioanalysis.
Today, our proven bench automation platforms and growing digital infrastructure support consistent, high-quality execution across our global labs.
We’re investing in connected systems and modern workflows that strengthen data integrity, traceability, and compliance — from sample receipt to final report.
Every step is documented.
Every data point is captured.
Every result is supported by evidence.
With millions of validated tests delivered each year, we combine operational scale with a clear roadmap for expanded automation.
And as we continue to invest, human oversight remains central — ensuring regulatory confidence at every stage.
Built to grow with your program — every step of the way.
A BIOANALYTICAL PARTNER BUILT FOR REGULATORY CONFIDENCE
We partner with biopharmaceutical sponsors to design bioanalytical strategies that align with global regulatory requirements, including GMP, GLP, GCP, CLIA, and IDE/IVDR standards.
With millions of validated assays delivered annually and decades of regulatory engagement, our teams understand what it takes to support clinical development, regulatory submissions, audits, and long-term program success.
Our role extends beyond testing. We serve as a scientific, technical, and operational partner, helping you navigate the complexity of drug development with clarity, consistency, and confidence.
READY TO SUPPORT WHAT’S NEXT IN BIOANALYSIS
With established capabilities, scalable laboratory infrastructure, and a clear roadmap for continued automation and digital integration, BioAgilytix is built to grow alongside your program.
Wherever your science leads, we’re ready to support it with scientific rigor, reliable data delivery, and regulatory excellence.
Getting RNA Immunogenicity Right: Strategic Considerations for Reliable Assessment
Lynn Kamen, PhD, Scientific Officer
Specialized Workshop- F2: Cell, Gene, and Vaccine Technologies – Latest Advances, Challenges, and Solutions from Internationally Recognized Key Opinion Leaders

A Novel SPEAD-Based Approach to Overcome Steric Hindrances in GLP-1 Peptide Therapeutic ADA Assay
Jamie Friedman
Intact and Signature Peptide LCMS Bioanalysis of Three Peptide-Pegylated lipid Conjugates from a Nanoparticle Formulation
Christian Smith

About the event
The 20th WRIB (Workshops on Recent Issues in Bioanalysis), taking place April 13–17, 2026 in Dallas, builds on the success of its previous meetings, including the 19th WRIB, which attracted more than 1,200 global professionals from pharma, biotech, CROs, and regulatory agencies. Renowned for its focus on high-quality science, regulatory compliance, and practical problem-solving, WRIB features internationally recognized thought leaders, extensive regulator engagement, evolving case studies based on prior white papers, and a highly interactive format. Attendees can choose between full three-day immersion workshops, focused two-day tracks, and specialized training sessions, all delivered in a sequential, logistics-friendly setting with included meals and comprehensive printed materials. Organized by CFABS, WRIB offers both in-person and remote participation and is designed to provide attendees with actionable insights, direct regulatory dialogue, and in-depth learning in bioanalysis.

Schedule a meeting with our experts on site
© Copyright 2026 BioAgilytix Labs. All rights reserved.